Clearsynth

Clearsynth logo

Clearsynth is a technology based, research driven enterprise with the World's Largest Inventory of Reference Standards & Research Chemicals. We aim to enable the research community in accelerated discovery via synthesis of complex and difficult to make compounds. We specialize in Innovative Organic chemistry and synthesis of Unique Complex Molecules, Stable Isotope Labelled compounds, Metabolites, Impurities, Glucuronides, Chiral Compounds, Conjugate Impurities, and Radioactive Labelled Compounds. We also undertake synthesis of complex Molecules or "Difficult to Synthesize" compounds/Intermediates. We have a strong commitment towards improving our quality systems, to deliver products that meet and exceed the needs of our customers and regulatory body mandates.

Company Website

Product Listing

boc-trans-Hydroxy-L-proline 500 g  | >98%

Clearsynth

boc-trans-Hydroxy-L-proline is used in the preparation of hydroxyproline derivatives. boc-trans-Hydroxy-L-proline is an intermediate in the synthesis of Fosinopril-d5 Sodium Salt , the labeled analogue of Fosinopril Sodium Salt , a phosphinic acid containing angiotensin converting enzyme (ACE) inhibitor. Antihypertensive.

More Information Supplier Page

Bortezomib 1R, 2R Isomer 500 g  | >98%

Clearsynth

(1R,2R)-Bortezomib is a diastereomer of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway

More Information Supplier Page